Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 48433-010

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 48433-010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Safecor Health, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Unit Carton (Export 00)

Atorvastatin Calcium tablet packaging label by Safecor Health, LLC. The label features the UDL logo and states it is a unit dose package not child resistant, intended for institutional use only. It advises keeping drugs out of children's reach and notes light-resistant container properties. Contact information and distributor location in Rockford, IL, are provided.*

FDA Label Image

Atorvastatin Calcium Tablets, Usp 80 mg Unit Carton Label (Export 01)

The label for Atorvastatin Calcium Tablets, USP 80 mg from Safecor Health, LLC. It displays the NDC 48433-010-03 and features an image of the 80 mg tablet marked with '80'. The label indicates a package size of 30 tablets (5 bottles of 6 tablets each), with storage instructions and manufacturer information from Mylan Pharmaceuticals Inc., Morgantown, WV.*

FDA Label Image

Atorvastatin Calcium Structural Formula (Image 01)

Chemical structure of atorvastatin calcium dihydrate, showing the calcium ion and three water molecules associated with the molecular complex.*

FDA Label Image

Atorvastatin Calcium Tablets, Usp 10 mg Unit Carton Label (Image 02)

Label for Atorvastatin Calcium 10 mg film-coated tablets, USP, from Safecor Health, LLC. The label shows two images of an oval white tablet imprinted with '10'. It indicates the product is prescription-only, with a package size of 100 tablets (10 x 10). Storage instructions specify 20 to 25°C. Manufactured for Mylan Pharmaceuticals Inc., Morgantown, WV, USA, and made in India.*

FDA Label Image

Atorvastatin Calcium Tablets, Usp 10 mg Unit Carton Label (Image 03)

Atorvastatin Calcium Tablets, USP 20 mg film-coated oral tablets by Safecor Health, LLC. The label shows an imprint "20" on a white oval tablet. Packaging indicates 100 tablets (10 x 10) in a prescription drug format. Manufacturing details include Mylan Pharmaceuticals Inc., Morgantown, WV, USA, and reference to storage conditions and dosage guidance.*

FDA Label Image

Atorvastatin Calcium Tablets, Usp 40 mg Unit Carton Label (Image 04)

Atorvastatin Calcium 40 mg film-coated tablets, USP, shown in a label design for a 100-count package (10 tablets per blister, 10 blisters). The label includes the NDC 48433-009-20, and depicts a white, elliptical tablet engraved with '40'. The label identifies Safecor Health, LLC as the labeler, with manufacturing by Mylan Pharmaceuticals Inc. in Morgantown, WV, and indicates the product is for prescription use only.*

FDA Label Image

Figure 1: Effect Of Atorvastatin Calcium Tablets 10 mg/day On Cumulative Incidence Of Non-fatal Myocardial Infarction Or Coronary Heart Disease Death (in Ascot-lla) (Image 06)

A cumulative incidence line graph comparing Atorvastatin and placebo over a period of up to 3.5 years. The y-axis represents cumulative incidence percentage, and the x-axis represents time in years. The graph shows lower incidence for Atorvastatin compared to placebo, with hazard ratio and p-value noted.*

FDA Label Image

Figure 2: Effect Of Atorvastatin Calcium Tablets 10 mg/day On Time To Occurrence Of Major Cardiovascular Event (myocardial Infarction, Acute Chd Death, Unstable Angina, Coronary Revascularization, Or (Image 07)

A line graph comparing the cumulative hazard percentages over time between placebo and atorvastatin groups. The x-axis represents time in years up to four years of follow-up, while the y-axis shows cumulative hazard percentage. The atorvastatin group has a consistently lower hazard compared to placebo, as indicated by the curves and statistical values shown on the graph.*

FDA Label Image

Figure 3: Effect Of Atorvastatin Calcium Tablets 80 mg/day Vs. 10 mg/day On Time To Occurrence Of Major Cardiovascular Events (tnt) (Image 08)

A line graph comparing the percentage of subjects experiencing a major cardiovascular event over time between two atorvastatin dosage groups, 10 mg and 80 mg. The x-axis shows time in years (0 to 5), and the y-axis represents the percentage of subjects experiencing the event. The graph includes hazard ratio and p-value data indicating statistical comparison between the groups.*

FDA Label Image

Unit Carton (Image 09)

Packaging label for Atorvastatin Calcium unit dose by Safecor Health, LLC. The label includes the UDL logo and states that the unit dose package is not child resistant, for institutional use only, and provides light resistance. It includes storage warnings and distributor information from Safecor Health LLC, Rockford, IL.*

FDA Label Image

Unit Carton (Image 10)

Blue packaging label for Atorvastatin Calcium film-coated tablets by Safecor Health, LLC. The label features the UDL logo with the text 'A Safecor Health Company' and includes distributor information and safety instructions. It is intended for institutional use only, specifying it is not child resistant and provides light resistance.*

FDA Label Image

Unit Carton (Image 11)

A blue packaging label from UDL, a Safecor Health Company. It includes the company logo, contact information, and safety warnings such as the package not being child resistant, for institutional use only, and instructions to keep out of reach of children. The label notes the container provides light resistance and advises checking the window for lot number and expiration date. Distributed by Safecor Health, Rockford, IL.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.